Table 1.
Inclusion criteria | Exclusion criteria |
---|---|
At least 18 years old | Known anaphylactic or allergic reactions to folate and its analogs |
Proven or suspected diagnosis of cT1-2 RCC by CT assessment | Known sensitivity to fluorescent light |
Scheduled for partial nephrectomy | Renal impairment (baseline GFR below 50 mL/min/1.73 m2) |
Expected survival of at least 3 months | Hepatic disorders (CTCAE version 4 definition ≥ grade 2) |
Good performance status (ECOG ≤1) | Brain metastases |
Negative serum or urine pregnancy test within 24 hours before partial nephrectomy (for females of child-bearing age) | Participation in another investigational drug trial within 30 days before partial nephrectomy |
Willingness to participate after the process of informed consent | Any medical conditions that, in the opinion of the investigators, could potentially jeopardize patient's safety, limit the patient's ability to complete the study, or compromise the objectives of the study |
CTCAE = Common Terminology Criteria for Adverse Events; ECOG = Eastern Cooperative Oncology Group; GFR = glomerular filtration rate; RCC = renal-cell carcinoma.